Literature DB >> 35083663

The 40-Hz White Light-Emitting Diode (LED) Improves the Structure-Function of the Brain Mitochondrial KATP Channel and Respiratory Chain Activities in Amyloid Beta Toxicity.

Maryam Nazari1,2, Taha Vajed-Samiei3, Nihad Torabi4, Javad Fahanik-Babaei5, Reza Saghiri6, Fariba Khodagholi7, Afsaneh Eliassi8,9.   

Abstract

It has been described that using noninvasive exposure to 40-Hz white light LED reduces amyloid-beta, a peptide thought to initiate neurotoxic events in Alzheimer's disease (AD). However, the mechanisms remain to be identified. Since AD impairs mitochondrial potassium channels and respiratory chain activity, the objectives of the current study were to determine the effect of 40-Hz white light LED on structure-function of mitoKATP channel and brain mitochondrial respiratory chain activity, production of reactive oxygen species (ROS), and ΔΨm in AD. Single mitoKATP channel was considered using a channel incorporated into the bilayer lipid membrane and expression of mitoKATP-Kir6.1 subunit as a pore-forming subunit of the channel was determined using a western blot analysis in Aβ1-42 toxicity and light-treated rats. Our results indicated a severe decrease in mito-KATP channel permeation and Kir6.1 subunit expression coming from the Aβ1-42-induced neurotoxicity. Furthermore, we found that Aβ1-42-induced neurotoxicity decreased activities of complexes I and IV and increased ROS production and ΔΨm. Surprisingly, light therapy increased channel permeation and mitoKATP-Kir6.1 subunit expression. Noninvasive 40-Hz white light LED treatment also increased activities of complexes I and IV and decreased ROS production and ΔΨm up to ~ 70%. Here, we report that brain mito-KATP channel and respiratory chain are, at least in part, novel targets of 40-Hz white light LED therapy in AD.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; LED therapy; MitoKATP channel; Mitochondria; Respiratory chain activity

Mesh:

Substances:

Year:  2022        PMID: 35083663     DOI: 10.1007/s12035-021-02681-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  62 in total

1.  Blue light inhibits mitosis in tissue culture cells.

Authors:  L A Gorgidze; S A Oshemkova; I A Vorobjev
Journal:  Biosci Rep       Date:  1998-08       Impact factor: 3.840

2.  Gamma frequency entrainment attenuates amyloid load and modifies microglia.

Authors:  Hannah F Iaccarino; Annabelle C Singer; Anthony J Martorell; Andrii Rudenko; Fan Gao; Tyler Z Gillingham; Hansruedi Mathys; Jinsoo Seo; Oleg Kritskiy; Fatema Abdurrob; Chinnakkaruppan Adaikkan; Rebecca G Canter; Richard Rueda; Emery N Brown; Edward S Boyden; Li-Huei Tsai
Journal:  Nature       Date:  2016-12-07       Impact factor: 49.962

3.  Low-level laser therapy for beta amyloid toxicity in rat hippocampus.

Authors:  Yujiao Lu; Ruimin Wang; Yan Dong; Donovan Tucker; Ningjun Zhao; Md Ejaz Ahmed; Ling Zhu; Timon Cheng-Yi Liu; Robert M Cohen; Quanguang Zhang
Journal:  Neurobiol Aging       Date:  2016-10-11       Impact factor: 4.673

Review 4.  Neurological and psychological applications of transcranial lasers and LEDs.

Authors:  Julio C Rojas; F Gonzalez-Lima
Journal:  Biochem Pharmacol       Date:  2013-06-24       Impact factor: 5.858

Review 5.  Effect of pulsing in low-level light therapy.

Authors:  Javad T Hashmi; Ying-Ying Huang; Sulbha K Sharma; Divya Balachandran Kurup; Luis De Taboada; James D Carroll; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2010-08       Impact factor: 4.025

6.  Noninvasive 40-Hz light flicker to recruit microglia and reduce amyloid beta load.

Authors:  Annabelle C Singer; Anthony J Martorell; J Miller Douglas; Fatema Abdurrob; Matthew K Attokaren; John Tipton; Hansruedi Mathys; Chinnakkaruppan Adaikkan; Li-Huei Tsai
Journal:  Nat Protoc       Date:  2018-08       Impact factor: 13.491

7.  Syndrome of encephalopathy, petechiae, and ethylmalonic aciduria.

Authors:  M T García-Silva; A Ribes; Y Campos; B Garavaglia; J Arenas
Journal:  Pediatr Neurol       Date:  1997-09       Impact factor: 3.372

8.  Evaluation of the efficacy of low-level light therapy using 1072 nm infrared light for the treatment of herpes simplex labialis.

Authors:  G Dougal; S Y Lee
Journal:  Clin Exp Dermatol       Date:  2013-06-03       Impact factor: 3.470

9.  Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Authors:  Stephen Salloway; Reisa Sperling; Nick C Fox; Kaj Blennow; William Klunk; Murray Raskind; Marwan Sabbagh; Lawrence S Honig; Anton P Porsteinsson; Steven Ferris; Marcel Reichert; Nzeera Ketter; Bijan Nejadnik; Volkmar Guenzler; Maja Miloslavsky; Daniel Wang; Yuan Lu; Julia Lull; Iulia Cristina Tudor; Enchi Liu; Michael Grundman; Eric Yuen; Ronald Black; H Robert Brashear
Journal:  N Engl J Med       Date:  2014-01-23       Impact factor: 91.245

Review 10.  Shining light on the head: Photobiomodulation for brain disorders.

Authors:  Michael R Hamblin
Journal:  BBA Clin       Date:  2016-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.